It seems the most advanced program is still at Phase 2 at best?
Any estimate on timing/duration of clinical trials for FDA approval? Phase 3 required I'd guess?
Three years from now enough?
The market conditions for small cap pre-money/pre-deal bios are not very friendly at the moment. I like the look of it, but patience seems to be needed.
Ann: H1 2023 Preclinical and Clinical Programs Update, page-116
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.040(2.42%) |
Mkt cap ! $267.8M | |||
| Open | High | Low | Value | Volume |
| $1.71 | $1.71 | $1.54 | $370.9K | 232.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 392 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 13999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.58 |
Change
-0.040 ( 6.08 %) |
||||
| Open | High | Low | Volume | ||
| $1.62 | $1.65 | $1.54 | 41933 | ||
| Last updated 15.58pm 15/05/2024 ? | |||||
| RAC (ASX) Chart |